Precision Medicine News and Updates | Precision Medicine Online
网页The radiopharmaceutical, already approved for SSRT-expressing GEP-NETs, may be a new option in meningioma if future research validates findings from this small study. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
AstraZeneca Advancing Plan to Launch Biomarker-Driven Drugs as ...
网页1 天前 · NEW YORK – AstraZeneca and Daiichi Sankyo's filing last week seeking approval for Enhertu (trastuzumab deruxtecan) in HER2-low and -ultralow hormone receptor (HR)-positive advanced breast cancer represents a new milestone in AstraZeneca's mission to replace chemotherapy with targeted, biomarker-driven therapies across breast cancer subtypes.. Under an initiative announced in July 2023, the ...
FDA Approves Genentech's Itovebi Combo for PIK3CA-Mutated …
网页1 天前 · NEW YORK – The US Food and Drug Administration on Thursday approved Genentech's PI3Kα inhibitor Itovebi (inavolisib) with Pfizer's CDK4/6 inhibitor Ibrance (palbociclib) and the anti-estrogen therapy fulvestrant as a combination treatment for patients with advanced, PIK3CA-mutated, hormone receptor-positive, HER2 …
Immatics Moving PRAME-Directed Autologous TCR T-Cell …
网页1 天前 · NEW YORK – Following positive data from a Phase Ib clinical trial, Immatics is moving its T-cell receptor (TCR) therapy IMA203 into a Phase III, registration-directed study. The firm announced data from the Phase Ib trial of IMA203 in patients with metastatic melanoma whose tumors haven't ...
CHOP, Penn Get $14M NIH Grant to Develop Prime-Editing …
网页2 天之前 · NEW YORK – The Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia have received a $14 million grant to research gene-editing approaches for treating rare metabolic diseases, the organizations said Thursday. Researchers will use the four-year ...
Precision Oncology News - Precision Medicine Online
网页2024年10月4日 · UK Consortium Launches With Public-Private Funding to ID Immunotherapy Biomarkers. The Francis Crick Institute and the Royal Marsden Foundation Trust are spearheading the MANIFEST project with £21.9 million in government and industry funding. Oct 7, 2024.
Breaking News - Precision Medicine Online
网页5 天之前 · Velsera, Diagnóstica Longwood Partner for Precision Genomics Medicine in Spain, Portugal. The collaboration will bring together Velsera's clinical genomics analysis software with Diagnóstica Longwood's regional distribution knowledge and …
Precision Medicine Diagnostics
网页2024年10月1日 · The authors of a commentary said they view recent study results as informative, though limited, regarding the test's performance in prostate cancer. BioAI Aims to Expand Biomarker Prediction Tech Into Companion Diagnostics. The firm sees potential for AI algorithms to support drug development by …
COVID-19 Precision Oncology News | Precision Medicine Online
网页2020年3月24日 · News and reporting on COVID-19 from Precision Medicine Online Precision Oncology
Cardiovascular Disease Research News - Precision Medicine Online
网页2024年8月12日 · News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more from Precision Medicine Online.